pubmed-article:2415119 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2415119 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:2415119 | lifeskim:mentions | umls-concept:C0006684 | lld:lifeskim |
pubmed-article:2415119 | lifeskim:mentions | umls-concept:C0040779 | lld:lifeskim |
pubmed-article:2415119 | lifeskim:mentions | umls-concept:C0034284 | lld:lifeskim |
pubmed-article:2415119 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
pubmed-article:2415119 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:2415119 | pubmed:dateCreated | 1985-11-25 | lld:pubmed |
pubmed-article:2415119 | pubmed:abstractText | The action of trapidil (RocornalR) and its derivatives AR 12-456 and AR 12-160 on the inward calcium current (ICa) was studied in mouse neuroblastoma x rat glioma hybrid cells of the line 108CC5 under voltage clamp conditions by means of a suction pipette method. A dissociation constant of the calcium channel-trapidil complex of 277 microM was estimated for the initial inhibition of ICa by trapidil. Half maximal block of ICa was produced by 80 +/- 20 microM AR 12-456 and 500 +/- 150 microM AR 12-160. | lld:pubmed |
pubmed-article:2415119 | pubmed:language | eng | lld:pubmed |
pubmed-article:2415119 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2415119 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2415119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2415119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2415119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2415119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2415119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2415119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2415119 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2415119 | pubmed:issn | 0232-766X | lld:pubmed |
pubmed-article:2415119 | pubmed:author | pubmed-author:WollenbergerA... | lld:pubmed |
pubmed-article:2415119 | pubmed:author | pubmed-author:KrauseE GEG | lld:pubmed |
pubmed-article:2415119 | pubmed:author | pubmed-author:SchubertBB | lld:pubmed |
pubmed-article:2415119 | pubmed:author | pubmed-author:HeringSS | lld:pubmed |
pubmed-article:2415119 | pubmed:author | pubmed-author:BodeweiRR | lld:pubmed |
pubmed-article:2415119 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2415119 | pubmed:volume | 44 | lld:pubmed |
pubmed-article:2415119 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2415119 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2415119 | pubmed:pagination | K37-41 | lld:pubmed |
pubmed-article:2415119 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
pubmed-article:2415119 | pubmed:meshHeading | pubmed-meshheading:2415119-... | lld:pubmed |
pubmed-article:2415119 | pubmed:meshHeading | pubmed-meshheading:2415119-... | lld:pubmed |
pubmed-article:2415119 | pubmed:meshHeading | pubmed-meshheading:2415119-... | lld:pubmed |
pubmed-article:2415119 | pubmed:meshHeading | pubmed-meshheading:2415119-... | lld:pubmed |
pubmed-article:2415119 | pubmed:meshHeading | pubmed-meshheading:2415119-... | lld:pubmed |
pubmed-article:2415119 | pubmed:meshHeading | pubmed-meshheading:2415119-... | lld:pubmed |
pubmed-article:2415119 | pubmed:meshHeading | pubmed-meshheading:2415119-... | lld:pubmed |
pubmed-article:2415119 | pubmed:meshHeading | pubmed-meshheading:2415119-... | lld:pubmed |
pubmed-article:2415119 | pubmed:meshHeading | pubmed-meshheading:2415119-... | lld:pubmed |
pubmed-article:2415119 | pubmed:meshHeading | pubmed-meshheading:2415119-... | lld:pubmed |
pubmed-article:2415119 | pubmed:year | 1985 | lld:pubmed |
pubmed-article:2415119 | pubmed:articleTitle | Trapidil and other 5-triazolo-(1, 5-alpha)-pyrimidine derivatives as calcium channel blockers in 108CC5 cells. | lld:pubmed |
pubmed-article:2415119 | pubmed:publicationType | Journal Article | lld:pubmed |